Form 8-K - Current report:
SEC Accession No. 0001437749-20-002863
Filing Date
2020-02-18
Accepted
2020-02-18 10:58:15
Documents
4
Period of Report
2020-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200211_8k.htm 8-K 28060
2 EXHIBIT 10.1 ex_172373.htm EX-10.1 176478
3 EXHIBIT 99.1 ex_172707.htm EX-99.1 17059
4 ex_172707img001.gif GRAPHIC 26904
  Complete submission text file 0001437749-20-002863.txt   259950
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20624028
SIC: 2834 Pharmaceutical Preparations